Mode
Text Size
Log in / Sign up
N/A Completed N=4 Treatment

A Feasibility Open Trial of App-Enhanced Brief CBT for Suicidal Inpatients

Suicidal and Self-injurious Behavior
Source: ClinicalTrials.gov NCT05486091 ↗
Enrolled (actual)
4
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcomePrimary: Client Satisfaction at Discharge — 29.00 score on a scale

Summary

The purpose of this study is to evaluate the feasibility of integrating Brief Cognitive-Behavioral Therapy (BCBT) counseling with a software application (app) to prevent future suicidal thoughts and behaviors.

Outcome Measures

OutcomeResultp-value
PRIMARY
Client Satisfaction at Discharge
29.00 —
PRIMARY
App Usability at Discharge
95.00 —
PRIMARY
Frequency of Suicide Attempts
— —
PRIMARY
Suicidal Ideation Baseline
82.00 —
PRIMARY
Suicidal Ideation at Discharge
46.67 —
PRIMARY
Suicidal Ideation 1 Month
21.00 —
PRIMARY
Suicidal Ideation 2 Months
25.00 —
PRIMARY
Suicidal Ideation 3 Months
45.00 —

Eligibility Criteria

Inclusion Criteria

  • History of suicide attempt (lifetime) AND active ideation (with or without plan or intent) on admission
  • Own and have access to their phone (iPhone or Android with capability to download apps) during their inpatient stay
  • Ability to understand the nature of the study and provide written informed consent
  • Willing and able to provide at least two verifiable contacts for emergency or tracking purposes
  • Expected length of stay long enough to complete the entire treatment protocol

Exclusion Criteria

  • Not fluent in English
  • Experiencing current mania or psychosis
  • Have lifetime history of schizophrenia spectrum disorder, intellectual disability, or organic brain illness
  • Inpatient treatment plan includes detox protocol or electroconvulsive therapy
  • Any other psychiatric or medical condition that in the investigator's opinion would preclude informed consent or participation in the trial
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05486091). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search